IDEXX Laboratories Inc (IDXX) operating KPIs
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 19/309% above fair value
$551.21−24.77 (-4.30%)
Close on Oct 30, 2026Market cap $43.42BP/E 38.8Yield –
KPIs
Operating metrics that drive IDEXX Laboratories's business
Coming soon
This tab will track the numbers specific to IDEXX Laboratories's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.